Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
2.610
+0.005 (0.19%)
Nov 13, 2026, 4:00 PM EST - Market closed

Company Description

Bluejay Diagnostics, Inc. operates as a medical diagnostics company.

It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force.

The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings.

In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform.

Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Bluejay Diagnostics, Inc.
Bluejay Diagnostics logo
CountryUnited States
Founded2015
IPO DateNov 10, 2021
IndustryMedical Devices
SectorHealthcare
Employees6
CEOIndranil Dey

Contact Details

Address:
360 Massachusetts Avenue, Suite 203
Acton, Massachusetts 01720
United States
Phone844 327 7078
Websitebluejaydx.com

Stock Details

Ticker SymbolBJDX
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$10.00
CIK Code1704287
CUSIP Number095633707
ISIN NumberUS0956337077
Employer ID47-3552922
SIC Code3841

Key Executives

NamePosition
Kevin VanceChief Commercial Officer
Mark W. Feinberg M.D., Ph.D.Chief Medical Advisor
Dr. Mark W. Feinberg M.D.Chief Medical Advisor

Latest SEC Filings

DateTypeTitle
Nov 13, 20268-KCurrent Report
Nov 12, 202610-QQuarterly Report
Nov 10, 2026SCHEDULE 13G/AFiling
Nov 4, 20268-KCurrent Report
Oct 13, 20268-KCurrent Report
Oct 6, 20268-KCurrent Report
Sep 8, 20268-KCurrent Report
Aug 14, 2026SCHEDULE 13GFiling
Aug 13, 2026SCHEDULE 13GFiling
Aug 13, 20268-KCurrent Report